European Association for Cancer Research 2026 Congress

Illumina at EACR 2026​

Illumina will be exhibiting at EACR 2026 and we look forward to connecting with you during the congress. Stop by our booth, 80 to meet our experts and learn how integrated multiomic approaches are helping advance cancer research.​

We also invite you to attend our two Sponsored Industry Symposia, where researchers from academia and industry will share how combining multiple molecular layers, across genomics, proteomics, and spatial biology, is enabling deeper insight into cancer biology.​
​

Illumina / SomaLogic Mega Symposium​

Multi‑resolution and Multiomic Approaches to Decipher the Tumor Ecosystem​
Monday, 8 June 2026 | 12:15–14:00 | Room F1+2+3​

• Nadia Sedlyarova, PhD, Marketing Business Partner, Illumina - Expanding the Resolution and Scope of Multi‑modal Cancer Research with Innovative Solutions​

• Bodour Salhia, PhD, Inaugural (Interim) Chair & Associate Professor, Department of Cancer Biology, Keck School of Medicine of USC - The Power of OvaPrint and Novel Multi‑modal Methods for the Detection of Ovarian Cancer​

• Tala Khosroheidari, Director, Global Scientific Engagement and Application, SomaLogic - Introduction​

• Yehonatan Elon, Chief Technology Officer, OncoHost - Plasma proteomics and AI: Redefining precision oncology​

• Joachim Schmid, PhD, Vice President, Data Platforms & Multiomics, Illumina - Making Sense of Multiomics Data: Technical Considerations for Integrated Analysis and Visualisation​

Illumina Sponsored Symposium​

Multiomics Realized: Transforming Cancer Research Through Integrated Biological Insights​
Wednesday, 10 June 2026 | 13:30–14:15 | Room F1+2+3​

• Kyle Miller, Associate Director, Global Product Marketing, Illumina - Opening​

• Dr Ania Piskorz, PhD, Head of Genomics, CRUK Cambridge Institute, University of Cambridge - Multidimensional Understanding of Cancer: Initial Feedback from Illumina Spatial Solution​

• Dr Ariane Hallermayr, PhD, Head of Research & Development, Medical Genetics Center (MGZ) - Expanding cfDNA Whole‑Genome Analysis with Integrated Genetic, Fragmentomic, and Epigenetic Signals​